Suppr超能文献

采用桡动脉作为次级移植物的冠状动脉旁路移植术可改善患者生存率。

Coronary artery bypass graft surgery using the radial artery as a secondary conduit improves patient survival.

机构信息

Division of Cardiothoracic Surgery, Cedars Sinai Heart Institute, Los Angeles, CA.

出版信息

J Am Heart Assoc. 2013 Aug 22;2(4):e000266. doi: 10.1161/JAHA.113.000266.

Abstract

BACKGROUND

The clinical benefits of the left internal thoracic artery-to-left anterior descending coronary artery graft are well established in coronary artery bypass graft surgery (CABG). However, limited data are available regarding the long-term outcome of the radial artery (RA) as a secondary conduit over the established standard of the saphenous venous graft.

METHODS AND RESULTS

We compared the 12-year survival outcome in a set of propensity-matched CABG patients who received either the RA or the saphenous vein as a secondary conduit. A multivariable logistic regression that included 18 baseline characteristics was used to define the propensity of receiving an RA graft. The propensity model resulted in 260 matched pairs who underwent first-time isolated CABG from 1996 to 2001 with similar preoperative characteristics (C statistic=0.86). The cumulative 12-year survival estimated by use of the Kaplan-Meier method was higher for the RA graft patients (hazard ratio 0.76; P=0.03). This survival advantage was especially significant in diabetics (P=0.005), in women (P=0.02), and in the elderly (P=0.04.) The protective effect appeared beginning at year 5 post surgical intervention.

CONCLUSION

The RA as a secondary conduit provided superior long-term survival after CABG, especially in diabetic patients, women, and the elderly. This effect was most pronounced >5 years after surgery.

摘要

背景

左内乳动脉至左前降支冠状动脉搭桥术在冠状动脉旁路移植术(CABG)中具有良好的临床获益。然而,关于桡动脉(RA)作为次级移植物的长期结果的数据有限,而 RA 是公认的隐静脉移植物的标准。

方法和结果

我们比较了一组接受 RA 或隐静脉作为次级移植物的 CABG 患者的 12 年生存结果。使用包含 18 个基线特征的多变量逻辑回归来确定接受 RA 移植物的倾向。该倾向模型得出了 260 对在 1996 年至 2001 年期间接受首次孤立 CABG 的匹配患者,其术前特征相似(C 统计量=0.86)。Kaplan-Meier 方法估计的 12 年累积生存率对 RA 移植患者更高(风险比 0.76;P=0.03)。这种生存优势在糖尿病患者中更为显著(P=0.005),在女性中(P=0.02)和在老年人中(P=0.04)。这种保护作用在术后 5 年开始显现。

结论

RA 作为次级移植物在 CABG 后提供了更好的长期生存,尤其是在糖尿病患者、女性和老年人中。这种效果在手术后 5 年以上最为明显。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9c1/3828817/85b0bae6ba6f/jah3-2-e000266-g1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验